Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT05255328 Active, not recruiting - MELAS Syndrome Clinical Trials

Clinical Long Term Evaluation of Glutamine Supplement in MELAS Syndrome

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assesses the clinical efficacy of oral supplementation with glutamine over 3 years.

NCT ID: NCT05253729 Completed - Clinical trials for Carpal Tunnel Syndrome

Efficacy of Focused Shockwave Therapy in Patients With CTS

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Carpal tunnel syndrome (CTS) is the most common entrapment of upper extremity. Patients with CTS will experience symptoms of pain, numbness of tingling sensation along the median nerve distribution. In more severe case, patients may have difficult manipulating objects that disturb function and patient's quality of life. Extracorporeal Shockwave Therapy (ESWT) is one of physical modalities that uses to treat many musculoskeletal disorders. For CTS, previous evidence showed that ESWT can improve symptoms, function as well as electrophysiologic parameters. However, standardized guidelines as well as the study in patients with moderate to severe CTS has not been established. Thus, the objective of the present study was to evaluate efficacy of ESWT in term of symptoms, function, electrophysiologic parameters, as well as sonography of median nerve in patients with moderate to severe CTS.

NCT ID: NCT05252104 Not yet recruiting - Clinical trials for Thoracic Outlet Syndrome

Inter-rater Reliability of Diagnosing Thoracic Outlet Syndrome by Physiotherapists

Start date: April 1, 2022
Phase:
Study type: Observational

Thoracic outlet syndrome (TOS) denotes the collection of symptoms which may arise from compression of the neurovascular structures in the region of the brachial plexus. TOS has historically been a clinical enigma, with lack of consensus regarding its diagnosis limiting the validity of any research into it. Literature and local audit both note significant patient morbidity and redundant use of secondary care clinics and investigations in sufferers. The last decade has seen the creation of a consortium of leaders in the field and development of the CORE-TOS diagnostic tool. This tool has 5 subsets of clinical diagnostic criteria (CDC). Positivity in 4 or more suggests a diagnosis of TOS. The current study seeks to specifically examine whether physiotherapy clinicians - both in primary and secondary care - can consistently identify cases of TOS using the CORE-TOS tool and refer them appropriately to an extended scope physiotherapist (ESP) specialising in the condition. Specific education will be provided to relevant physiotherapists who will be asked to note all relevant CDC in any suspected cases thereafter referred to the ESP in an out-patient physiotherapy department setting. These referrals will follow the standard local pathway to physiotherapy and no clinical testing manoeuvres out with the current scope of physiotherapy will be applied. The patients' case notes will thereafter be retrospectively examined, and the inter-rater reliability of the CDC recorded by the both the referring physiotherapist on their referral and the researcher at initial review. This will analysed using intraclass correlation coefficient, SEM and Bland and Altman's agreement tests, coupled with descriptive analysis.

NCT ID: NCT05251935 Completed - Clinical trials for Pes Planus Down Syndrome Patients

Down Syndrome and Effects of Foot Muscle Exercise

Start date: April 22, 2021
Phase: N/A
Study type: Interventional

Down syndrome (DS) is a common chromosomal pediatric disorder and accounts for approximately 8 % of all congenital anomalies. Children with DS experience delays in Cognitive, Physical, Speech and Language development. Hypotonity and laxity that is part of its features causes delay on motor acquisition. Furthermore it causes musculoskeletal issues and lower extremity malalignment resulting in inefficient and abnormal pattern of movement compromising locomotion and day to day functions therefore, problems for the population further aggravates. Combined effects of these factors causes a high level of stress on foot as it provides the foundation for whole body therefore, individuals with Down syndrome are at risk for foot alignment problems. Pes planus being the most common amongst them and accounts for 91% of the total DS patients diagnosed. Pes planus causes alteration in foot kinetics and kinematics that not only interferes significantly with normal daily life activities as balance and gait but also increases the risk of musculoskeletal injuries. Hence researchers have shown interest in addressing this condition for the effective management of DS population. Conventional treatment approach are the use of insoles, foot orthosis and arch taping however, they fail to produce residual effect. Hence the present study is to determine the role of foot muscles exercises in Down Syndrome having pes planus since its effects are positively recorded in normal population.

NCT ID: NCT05251597 Recruiting - Metabolic Syndrome Clinical Trials

Comparison of the Effects of Green Exercise Programs on Metabolic Syndrome Parameters in Elderly Individuals

Start date: March 27, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to compare the effects of exercise programs that only aerobic exercise and combination aerobic exercise and resistance exercises on the metabolic syndrome parameters in the green exercise concept.

NCT ID: NCT05250596 Recruiting - Clinical trials for Non ST Segment Elevation Acute Coronary Syndrome

COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS)

COLOR-ACS
Start date: February 24, 2022
Phase: Phase 2
Study type: Interventional

Since colchicine is known to have anti-inflammatory effects and inflammation is an early component of acute coronary syndrome (ACS), this study aims to evaluate the acute effects of low-dose colchicine, in addition to atorvastatin, administered on-admission to statin-naive patients with non-ST elevation ACS scheduled for early invasive strategy.

NCT ID: NCT05250245 Completed - Clinical trials for Obstructive Sleep Apnea

Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome

Start date: June 1, 2020
Phase: Phase 4
Study type: Interventional

In this study, we aim to determine whether combined tolterodine and CPAP therapy is a more effective treatment for patients with OSAS than CPAP treatment only.

NCT ID: NCT05250037 Recruiting - Clinical trials for Hematopoietic and Lymphoid Cell Neoplasm

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

Start date: March 30, 2022
Phase:
Study type: Observational

This observational trial studies whether respiratory viruses are the cause of lung disease (bronchiolitis obliterans syndrome [BOS] or graft-versus-host disease of the lung) and changes in lung function in patients who have received a donor stem cell transplant. Patients with chronic graft-versus-host disease (cGVHD) are at higher risk of developing BOS. Studies have also shown that patients who had a respiratory viral illness early after their transplant are at higher risk of developing lung problems later on. Patients who are at risk and who already have BOS might benefit from being monitored more closely. Spirometry is a way of assessing a patient's lung function and is often used to diagnose lung disease. Spirometry measured at home with a simple handheld device may reduce the burden of performing pulmonary function testing at a facility and potentially help patients get their lung disease diagnosed and treated sooner.

NCT ID: NCT05249998 Recruiting - Obesity Clinical Trials

Improving Care of Prader-Willi Syndrome : Evaluation of a New Care Program Combining Adapted Physical Activity, Nutrition and Therapeutic Education

APHYNET
Start date: November 6, 2021
Phase: N/A
Study type: Interventional

Prader-Willi syndrome (PWS) is a rare and complex genetic disease characterized by hypothalamic-pituitary axis dysfunction combining eating disorders associated with hyperphagia and satiety deficiency, mild intellectual deficit and behavioral disorders. This disease requires continuous management through specific therapeutic education to prevent metabolic and cardiorespiratory complications related to obesity. Physical activity must therefore be regular, adapted to the disability, taking into account cognitive deficits and behavioral disorders. Prader-Willi syndrome (PWS) is a rare and complex genetic disease characterized by hypothalamic-pituitary axis dysfunction combining eating disorders associated with hyperphagia and satiety deficiency, mild intellectual deficit and behavioral disorders. This disease requires continuous management through specific therapeutic education to prevent metabolic and cardiorespiratory complications related to obesity. Physical activity must therefore be regular, adapted to the disability, taking into account cognitive deficits and behavioral disorders. The Unit of Care and Rehabilitation, of the Hôpital Marin d'Hendaye, receives patients with PWS or other obesity from rare causes, at a rate of 1 to 2 annual stays of 1 to 2 months, which allow the regulation of somatic disorders and the initiation of weight loss. However, the difficulty is to keep a stable weight curve between stays. Only 20% of patients over the last 2 years managed to stabilize or decrease their BMI during the 6 months following their hospitalization. The proposed study aims to evaluate an innovative and individualized care program combining Physical activity, Nutrition and therapeutic education for adults with PWS who will be admitted to the hospital for 5 weeks. We hypothesize that this program will allow to stabilize or decrease the BMI of patients at 6 months after hospitalization by inducing a behavioral change in terms of physical activity and eating behavior. We will conduct a randomized controlled trial on 128 patients who will participate in this program, or will benefit from standard care.

NCT ID: NCT05249673 Completed - Neck Syndrome Clinical Trials

Global Postural Reeducation Versus Neck Stabilization Training on Text Neck Syndrome.

Start date: January 26, 2022
Phase: N/A
Study type: Interventional

The study will be randomized control trial. The study will be conducted in Iqbal Mehmooda Trust Hospital. Group A will be treated with global postural reeducation. Group B will be treated with neck stabilization training. Non probability consecutive sampling technique will be used. Patient below 20-40 years, participants who use smart phones for 8 hours per day(guidelines), angle of forward head pasture above 15, screening picture tool. Neurological defects, trauma, tumor, shoulder injury, cervical disc disease. REBA questionnaire, NDI, Goniometry, NPRS will be used as a tool. The global postural reeducation will be applied on group A while neck stabilization training will be applied on group B. The aim of this study will be to compare the effects of of global postural reeducation and neck stabilization training on text neck syndrome.